Induction of c-fos mRNA in rat medial prefrontal cortex by antipsychotic drugs: Role of dopamine D2 and D3 receptors

Cerebral Cortex

Volumn 6, Issue 4, 1996, Pages 561-570

  Merchant, Kalpana M ^a   Figur, Lana M ^a   Evans, Dawna L ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 5,6 DIMETHOXYINDAN; CLOZAPINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; HALOPERIDOL; NEUROLEPTIC AGENT; REMOXIPRIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; GENE EXPRESSION; GENE INDUCTION; HYPOTHESIS; IMMEDIATE EARLY GENE; IMMUNOREACTIVITY; NONHUMAN; ONCOGENE C FOS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

EID: 0029799515     PISSN: 10473211     EISSN: None     Source Type: Journal    
DOI: 10.1093/cercor/6.4.561     Document Type: Article

References (47)

1. Ahlfors UG, Rimon R, Appleberg B, Hagert U, Harma P, Katila H, Mahlanen A, Mehtonen O.P, Naukkarinen H, Outakoski J, Rantanen H, Sorri A, Taminnen T, Tolvanen E, Holm A-C (1990) Remoxipride and haloperidol in schizophrenia: a double blind multicentre study. Acta Psychiatr Scand 82 (Suppl 358):99-103.
2. Andreasen NC, Arndt S, Swayze V, II, Cizadlo T, Flaum M, O'Leary D, Ehrhardt JC, Yuh WTC (1994) Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science 266:294-297.
3. Chen J, Ruan D, Paredes W, Gardner EL (1992) Effects of acute and chronic clozapine on dopaminergic function in medial prefrontal cortex of awake freely moving rats. Brain Res 571:235-241.
4. Deutch AY, Duman RS (1995) The effects of antipsychotic drugs on prefrontal cortical Fos expression; cellular localization and pharmacological characterization. Neuroscience 70:377-389.
5. Deutch AY, Moghaddam B, Innis, RB, Krystal, JH, Aghajanian, GK, Bunney BS, Charney, DS (1991) Mechanisms of actions of atypical antipsychotic drugs: implications for novel therapeutic strategies of schizophrenia. Schizophr Res 4:121-156.
6. Deutch AY, Lee MC, Iadarola, MJ (1992) Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: the nucleus accumbens shell as a locus of antipsychotic action. Mol Cell Neurosci 3:332-341.
7. Deutch AY, Ongur D, Duman RS (1995) Antipsychotic drugs induce Fos protein in the thalamic paraventricular nucleus; a novel locus of antipsychotic drug action. Neuroscience 66:337-346.
8. Diaz J, Levesque D, Griffon N, Lammers CH, Martres M-P, Sokoloff P, Schwartz J-C (1994) Opposing roles for D2 and D3 receptors on neurotensin mRNA expression in nucleus accumbens. Eur J Neurosci 6:1384-1387.
9. 2-dopamine receptor binding examined in vivo by PET. Acta Psychiatr Scand 82 (Suppl 358):67-71.
10. Fink-Jensen A, Kristensen P (1994) Effects of typical and atypical neuroleptics on Fos protein expression in rat forebrain. Neuroscience Lett 182:115-118.
11. Gerlach J (1991) New antipsychotics: classification, efficacy and adverse effects. Schizophrenia Bull 17: 289-309.
12. Griffon N, Diaz J, Levesque D, Sautel F, Schwartz J-C, Sokoloff P, Simon P, Costentin J, Garrido F, Mann A, Wermuth C (1995) Localization, regulation, and role of the dopamine D3 receptor are distinct from those of the D2 receptor. Clin Neuropharmacol 18:S130-S142.
13. Hall H, Sallmeark M, Jerning E (1986) Effects of remoxipride and some related new substituted salicylamides on rat brain receptors. Acta Pharmacol Toxicol 58:61-70.
14. Kane JM, Freeman HL (1994) Towards more effective antipsychotic treatment. Br J Psychiatr 165 (Suppl 25):22-31.
15. Kohler C, Hall H, Magnusson O, Lewander T, Gustafsson K (1990) Biochemical pharmacology of the atypical neuroleptic remoxipride. Acta Psychiatr Scand 82 (Suppl 358):27-36.
16. Landwehrmeyer B, Mengod G, Palacios JM (1993) Dopamine D3 receptor mRNA and binding sites in human brain. Mol Brain Res 18:187-192.
17. Lewander T, Westebergh S-E, Morrison D (1990) Clinical profile of remoxipride-a combined analysis of a comparative double-blind multicentre trial programme. Acta Psychiatr Scand 82 (Suppl 358):92-98.
18. MacGibbon GA, Lawlor PA, Bravo, R, Dragunow M (1994) Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja. Mol Brain Res 23:21-28.
19. 2b and D3 receptors. Mol Pharmacol 43:749-754.
20. Meador-Woodruff JH, Mansour A, Saul J, Watson SJ (1994) Neuroanatomical distribution of dopamine receptor messenger RNAs. In: Dopamine receptors and transporters: pharmacology, structure, and function (Niznik HB, ed.), pp 401-414. New York: Marcel Dekker.
21. Meltzer HY (1994) An overview of the mechanism of action of clozapine. J Clin Psychiatr 55 (Suppl B):47-52.
22. Mendelwicz J, de Bleeker E, Cosyns P, Deleu G, Lostra F, Masson A, Martens C, Parent M, PeuskensJ, Suy E, de Wile J, Wilmotte J, Norgard J (1990) A double-blind comparative study of remoxipride and haloperidol in schizophrenic and schizophreniform disorders. Acta Psychiatr Scand 82 (Suppl 358):138-141.
23. Merchant KM (1994) c-fos antisense oligonucleotide specifically attenuates haloperidol-induced increases in neurotensin/neuromedin N mRNA expression in rat dorsal striatum. Mol Cell Neurosci 5:336-344.
24. Merchant KM, Dorsa DM (1993) Differential induction of neurotensin and c-fos gene expression by typical vs. atypical antipsychotics. Proc Natl Acad Sci USA 90:3447-3451.
25. Merchant KM, Miller MA (1994) Coexpression of neurotensin and c-fos mRNAs in rat neostriatal neurons following acute haloperidol. Mol Brain Res 23:271-277.
26. Merchant KM, Dobie DJ, Dorsa DM (1992a) Expression of the proneurotensin gene in the rat brain and its regulation by antipsychotic drugs. Ann NY Acad Sci 668:54-69.
27. Merchant KM, Dobner PR, Dorsa DM (1992b) Differential effects of haloperidol and clozapine on neurotensin gene transcription in rat neostriatum. J Neurosci 12:652-663.
28. Merchant KM, Dobie DJ, Filloux F, Totzke M, Aravagiri M, Dorsa DM (1994) Effects of chronic haloperidol and clozapine treatment on neurotensin and c-fos mRNA in rat neostriatal subregions. J Pharmacol Exp Ther 271:460-471.
29. Miller JC (1990) Induction of c-fos mRNA expression in rat striatum by neuroleptic drugs. J Neurochem 54:1453-1455.
30. Mohell NA, Sallemark M, Rosqvist S, Malmberg A, Jackson DM (1993) Binding characteristics of remoxipride and its metabolites to dopamine D2 and D3 receptors. Eur J Pharmacol 238:121-125.
31. Ngyuen TV, Kasofsky B, Birnbaum R, Cohen B, Hyman SE (1991) Differential expression of c-fos and Zif 268 in rat striatum following haloperidol, clozapine and amphetamine. Proc Natl Acad Sci USA 89:4270-4274.
32. Ogren S-O, Florvall L, Hall H, Magnusson O, Angeby-Moller K (1990) Neuropharmacological and behavioral properties of remoxipride in the rat. Acta Psychiatr Scand 82 (Suppl 358):21-26.
33. 2 blocking activity and plasma concentrations of remoxipride and its main metabolites in the rat. J Neural Trans 93:187-203.
34. Paxinos G and Watson C (1986) The rat brain in stereotaxic coordinates. San Diego, CA: Academic Press.
35. Robertson GS, Fibiger HC (1992) Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine. Neuroscience 46:315-329.
36. Robertson GS, Matsumura H, Fibiger HC (1994) Induction of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J Pharamcol Exp Ther 271:1058-1066.
37. Robertson GS, Tetzlaff W, Bedard A, St-Jean M, Wigle N (1995) c-fos mediates antipsychotic-induced gene expression in the rodent striatum. Neuroscience 67:325-344.
38. Schwartz J-C, Levesque D, Martres M-P, Sokoloff P (1993) Dopamine D3 receptor: basis and clinical aspects. Clin Neuropharmacol 16: 295-314.
39. Sebens JB, Koch T, Ter Horst GJ, Korf J (1995) Differential Fos-protein induction in rat forebrain regions after acute and long-term haloperidol and clozapine treatment. Eur J Pharmacol 273: 175-182.
40. Seeman P (1992) Dopamine receptor sequences: therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. Neuropsychopharmacology 7: 261-284.
41. Sesack SR, Deutch AY, Roth RH, Bunney BS (1992) Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J Comp Neurol 290:213-242.
42. Sokoloff P, Martres M-P, Giros B, Bouthenet M-L, Schwartz J-C (1992) The third dopamine receptor (D3) as a novel target for antipsychotics. Biochem Pharmacol 43:659-663.
43. Walinder J, Holm AC (1990) Experience of long-term treatment with remoxipride: efficacy and tolerability. Acta Psychiatr Scand 82 (Suppl 358):158-163.
44. Waters N, Lofberg L, Haadsma-Svensson S, Svensson K, Sonesson C, Carlsson A (1994) Differential effects of dopamine D2 and D3 receptor antagonists in regard to release, in vivo receptor displacement and behaviour. J Neural Transm 98:39-55.
45. Waters N, Svensson K, Haadsma-Svensson SR, Smith MW, Carlsson A (1993) The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity. J Neural Transm 94:11-19.
46. Weinberger DR, Berman KF, Zec RF (1986) Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatr 43:114-124.
47. Youngren KD, Moghaddam B, Bunney BS, Roth RH (1994) Preferential activation of dopamine overflow by chronic clozapine treatment. Neurosci Lett 165:41-44.